Literature DB >> 29500833

Splice site mutation in COL7A1 resulting in aberrant in-frame transcripts identified in a case of recessive dystrophic epidermolysis bullosa, pretibial.

Takuji Masunaga1,2, Akiharu Kubo1, Akira Ishiko1,3.   

Abstract

Dystrophic epidermolysis bullosa (DEB), pretibial, a rare subtype of epidermolysis bullosa (EB), is characterized by recurrent blisters and erosions predominantly on the pretibial region. We report the case of a 60-year-old Japanese woman with persistent blistering eruptions and scar formation on the pretibial region and elbows. Mutational analysis revealed a previously reported c.5797C>T mutation in exon 70 (p.R1933X) and a novel c.6348+1G>A mutation in intron 76 of COL7A1. Reverse transcription polymerase chain reaction revealed that the c.6348+1G>A mutation resulted in the skipping of exon 76 (69 bp) and the retention of intron 76 (75 bp), and both transcripts were in-frame. From these results, we diagnosed the patient as having recessive DEB, pretibial. A review of previously reported mutations in DEB, pretibial, revealed that one-third of DEB, pretibial, cases showed a recessive inheritance pattern, and no case had a combination of premature termination codon (PTC)/PTC mutations. The DEB, pretibial, case described herein is the first reported case of a compound heterozygote with PTC/in-frame mutations. Although no special characteristic features of the mutations were identified, a high diversity of COL7A1 mutations was shown even in DEB, pretibial.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  basement membrane; blistering disease; genodermatosis; splice site mutation; type VII collagen

Mesh:

Substances:

Year:  2018        PMID: 29500833     DOI: 10.1111/1346-8138.14271

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  Pretibial dystrophic epidermolysis bullosa associated with aberrant exon splicing of type VII collagen.

Authors:  Patricia Richey; Melia Holt; Sydney Crotts; Ali Jabbari
Journal:  JAAD Case Rep       Date:  2019-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.